Latest news for Articore Group (OTC:RDBBF) Stock

Articore Group Ltd is an online marketplace that facilitates the sale and purchase of art and designs on variety of products between independent creatives and consumers. The name of the marketplace is Redbubble.com and TeePublic.com. The products are produced and shipped by third-party service providers (i.e. product manufacturers, printers, and shipping companies) referred to as fulfillers. The company's primary geographic markets are Australia, the United States, the United Kingdom, and the rest of the world. It has two reportable segments: Redbubble and TeePublic. The majority of its revenue is derived from the United States.

ARTICORE GROUP LTD by ARTICORE GROUP LTD.

Articore Group Ltd

BioVie Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIVI#NASDAQ">BIVI</a>), ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced that an&nbsp;abstract on the design of its planned Phase 2 trial evaluating bezisterim in Long COVID has been accepted as a poster presentation at the Demystifying Long COVID International Conference, November 21st &amp; 22nd 2024, in Barcelona Spain.
The planned Phase 2 study, which is fully funded by a grant from the U.S. Department of Defense (DOD), is a double-blind, randomized (1:1), placebo-controlled, multicenter trial in approximately 200 patients to evaluate the safety, tolerability and potential efficacy of 3 months of treatment with bezisterim to reduce the neurocognitive symptoms associated with Long COVID.

Biotech

News

General

BIVI

BioVie To Present Design Of Planned Phase 2 Study Of Bezisterim For The Treatment Of Long COVID At The Demystifying Long COVID International Conference

<a href="https://www.wolferesearch.com/eventsandconferences/" title="https://www.wolferesearch.com/eventsandconferences/">https://www.wolferesearch.com/eventsandconferences/</a>

Hess CEO Says Between President-Elect Trump And China, Demand For Oil Will Be Stronger Next Year

WIIM

ARGX

Argenx shares are trading higher after the company announced the decision to continue development of efgartigimod subcutaneous in the ongoing Phase 2/3 ALKIVIA study in adults with idiopathic inflammatory myopathies.

BrainsWay Ltd. (NASDAQ &amp; TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the publication of positive feasibility clinical data evaluating the analgesic effects of deep transcranial magnetic stimulation (Deep TMS&#x2122;)&nbsp;in patients with peripheral neuropathic pain. The results were published in the Neuromodulation journal, in a peer-reviewed <a href="https://www.globenewswire.com/Tracker?data=mXgOL4BnKoHbbstEk2zPvBpsiBp_O3Bgt3QvUcTeZWpQ_rRTtxB8WuQoCgOOtILF_DClycQR4U4uhgzUVjYjN4o5yphTX2X2iYd8xoAPn8Acw5_vgLstSmgUCJ0hrDhOrd-xMafK96FCUPLXp1mbBA==">article</a> entitled, "H-Coil Repetitive Transcranial Magnetic Stimulation Relieves Pain and Symptoms of Anxiety and Depression in Patients with Chronic Peripheral Neuropathic Pain: A Randomized Sham-Controlled Crossover Study."
The double-blind, randomized crossover trial included seventeen (17) patients with chronic neuropathic pain. Participants were assigned to either an active Deep TMS or sham treatment arm for a five-day period, followed by a nine-week washout, before crossing over to the other arm. The study's primary outcome measure was a comparison between the patterns of the active and sham groups' self-reported changes in pain levels from baseline. Secondary outcomes included changes in pain ratings at specific time points in the two arms, as well as changes in comorbid symptoms experienced by the patients, including, for example, anxiety and depression.&nbsp;
Results showed that Active deep-TMS therapy significantly reduced "usual pain intensity" in patients with chronic peripheral neuropathic pain compared to sham treatment and improved symptoms of anxiety and depression in the same patient population.

BWAY

BrainsWay Announces The Publication Of Feasibility Clinical Data Evaluating The Analgesic Effects Of Deep Transcranial Magnetic Stimulation In Patients With Peripheral Neuropathic Pain. The Results Were Published In The Neuromodulation Journal, In A Peer-Reviewed Article Entitled, "H-Coil Repetitive Transcranial Magnetic Stimulation Relieves Pain And Symptoms Of Anxiety And Depression In Patients With Chronic Peripheral Neuropathic Pain: A Randomized Sham-Controlled Crossover Study."

Stifel analyst Adam Borg maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Buy and raises the price target from $300 to $375.

Price Target

Analyst Ratings

CRWD

Stifel Maintains Buy on CrowdStrike Holdings, Raises Price Target to $375

Barclays analyst Brandt Montour maintains Viking Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIK#NYSE">VIK</a>) with a Overweight and raises the price target from $43 to $49.

Barclays Maintains Overweight on Viking Holdings, Raises Price Target to $49

Nokia shares are trading higher after the company was awarded a multi-year, multi-billion USD extension deal to deploy 4G and 5G equipment across Indian cities and states.

Stifel analyst Matthew Smith maintains BellRing Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRBR#NYSE">BRBR</a>) with a Buy and raises the price target from $67 to $81.

BRBR

Stifel Maintains Buy on BellRing Brands, Raises Price Target to $81

Barclays analyst Jiong Shao maintains Trip.com Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>) with a Overweight and raises the price target from $76 to $84.

TCOM

Barclays Maintains Overweight on Trip.com Group, Raises Price Target to $84

CHWY

Chewy shares are trading higher after B of A Securities upgraded the stock from Underperform to Buy and raised its price target from $24 to $40.

Stifel analyst Stephen Gengaro downgrades DMC Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOOM#NASDAQ">BOOM</a>) from Buy to Hold and lowers the price target from $16 to $8.

Downgrades

BOOM

Stifel Downgrades DMC Glb to Hold, Lowers Price Target to $8

Benchmark analyst Bruce Jackson reiterates Milestone Scientific (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MLSS#AMEX">MLSS</a>) with a Speculative Buy and maintains $1.25 price target.

Reiteration

MLSS

Benchmark Reiterates Speculative Buy on Milestone Scientific, Maintains $1.25 Price Target

KEYS

Keysight Techs shares are trading higher after the company reported better-than-expected Q4 financial results. Also, multiple firms raised their respective price targets on the stock.

Company growth continues in support of high-performance compute customers
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fcorescientific.com%2F&amp;esheet=54155709&amp;newsitemid=20241120134811&amp;lan=en-US&amp;anchor=Core+Scientific+Inc.&amp;index=1&amp;md5=76f2b34d9aeda6f0fcb62d21ab645f03">Core Scientific Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-performance computing and bitcoin mining, today announced the Denton City Council's approval of amendments to the Company's Power Purchase Agreements and land leases. The approval came during the Council's November 19 meeting.

Core Scientific, Inc. - Class A Common Stock

CORZ

Core Scientific Announces The Denton City Council's Approval Of Amendments To The Company's Power Purchase Agreements And Land Leases

Stifel analyst Selman Akyol maintains Targa Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRGP#NYSE">TRGP</a>) with a Buy and raises the price target from $190 to $224.

TRGP

Stifel Maintains Buy on Targa Resources, Raises Price Target to $224

Needham analyst Ami Fadia reiterates Sage Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGE#NASDAQ">SAGE</a>) with a Hold.

SAGE

Needham Reiterates Hold on Sage Therapeutics

TVGN

Tevogen Bio Holdings shares are trading higher after the company announced it internally developed an intellectual property portfolio and product assets valued at over $10 billion that does not currently reflect in the balance sheet.

New company to provide world-class news, sports and entertainment with significant scale and resources
Media veterans Mark Lazarus and Anand Kini to lead the new company
Comcast will continue its strategic focus on driving its core growth businesses, including residential broadband, wireless, business services and NBCUniversal's streaming, studios and theme parks
Tax-free transaction expected to be completed in approximately one year
Comcast Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) today announced its intent to create a new publicly traded company comprised of a strong portfolio of NBCUniversal's cable television networks, including USA Network, CNBC, MSNBC, Oxygen, E!, SYFY and Golf Channel along with complementary digital assets including Fandango and Rotten Tomatoes, GolfNow and Sports Engine, through a tax-free spin-off. The well-capitalized independent company ("SpinCo") will have significant scale as a pure-play set of assets anchored by leading news, sports and entertainment content.
SpinCo will be an industry-leading news, sports and entertainment cable television business with a focused strategic direction. SpinCo's stable of marquee brands will provide a diverse and differentiated content offering that will reach approximately 70 million U.S. households.

CMCSA

Comcast Announces Intention To Create Leading Independent Media Business Through Spin-off Of Select Cable Television Networks; New Company To Provide World-Class News, Sports And Entertainment With Significant Scale And Resources

Earnings

WILC

G. Willi-Food Intl Q3 Sales $41.20M Up From $33.4M YoY

Barclays analyst Theresa Chen maintains TC Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TRP#TSX">TRP</a>) with a Overweight and raises the price target from C$67 to C$74.

TSX:TRP

Barclays Maintains Overweight on TC Energy, Raises Price Target to C$74

Redbubble Ltd. (AU:ATG) has released an update. Articore Group Limited, an Australian-based company with a global presence, has released its FY24 a...

Articore Group Unveils Comprehensive FY24 Report

Redbubble Ltd. (AU:ATG) has released an update. Articore Group Limited has endorsed the 4th edition of the ASX Corporate Governance Principles and ...

Articore Group Commits to Strong Corporate Governance

Redbubble Ltd. (AU:ATG) has released an update. Articore Group Limited has disclosed its adherence to the ASX Corporate Governance Council's recomm...

Articore Group's Transparent Governance Report

Redbubble Ltd. (AU:ATG) has released an update. Articore Group Limited has announced the issue of new ordinary fully paid shares on three separate ...

Articore Group Announces New Share Issuance

Redbubble Ltd. (AU:ATG) has released an update. Articore Group, known for its online marketplaces Redbubble.com and TeePublic.com, announced a corr...

Articore Group Corrects FY2024 Annual Report Error

Redbubble Ltd. (AU:ATG) has released an update. Articore Group, previously known as Redbubble Ltd, has undergone significant transformation in FY24...

Articore Group's Strategic Overhaul and Positive Cash Flow

Redbubble Ltd. (AU:ATG) has released an update. Articore Group Ltd., formerly Redbubble Ltd., successfully passed most resolutions in its 2024 Annu...

Articore Group's AGM: Key Resolutions Passed with Strong Support

Redbubble Ltd. (AU:ATG) has released an update. Gregory Kilbourn Lockwood has ceased being a director of Articore Group Limited, effective October ...

Articore Group Sees Director Change Amid Stock Interests

Redbubble Ltd. (AU:ATG) has released an update. Robin Low, a director at Articore Group Limited, has increased his indirect stake by acquiring 58,2...

Articore Director Robin Low Boosts Shareholding

Redbubble Ltd. (AU:ATG) has released an update. Articore Group Limited has announced the appointment of John Lewis as a director, effective from Oc...

Comments

Articore Group

News

Latest news for Articore Group (OTC:RDBBF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga